AT189771T

Controlled release preparation containing a salt of morphine

Abstract

It is described a novel pharmaceutical composition which contains a number of coated particles containing morphine salt coated barrier membrane with a controlled release of morphine is preferably independent of the pH value during the main part of the dose interval when administered once daily, wherein the composition provides significantly reduced fluctuations of concentration plasma compared to known morphine compositions. It also discloses a method of making such a composition and the use of such composition for the manufacture of analgesics useful for the treatment of severe chronic bolesti.ŕ

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

50 members in 25 offices

This recordMember, by publication datePriority claim15 more offices are in the list below

Priority claims2

Priority claims
DocumentOfficeKindDate
9301057SwedenA
9400264SwedenW

Members50

Family members, oldest first
DocumentOfficeKind
SE9301057D0SwedenD0
SE9301057LSwedenL
CA2135639A1CanadaA1
WO9422431A1World Intellectual Property Organization (WIPO)A1
AU6439394AAustraliaA
FI945621AFinlandA
NO944565D0NorwayD0
NO944565LNorwayL
HU9403437D0HungaryD0
EP0642335A1European Patent Office (EPO)A1
PL306421A1PolandA1
CZ298694A3CzechiaA3
SK143794A3SlovakiaA3
LV10684ALatviaA
CN1106608AChinaA
HUT71417AHungaryA
JPH08501319AJapanA
LV10684BLatviaB
RU94046147ARussian FederationA
US5614218AUnited States of AmericaA
NZ263632ANew ZealandA
US5656291AUnited States of AmericaA
AU680891B2AustraliaB2
PL175326B1PolandB1
EE03147B1EstoniaB1
CZ284924B6CzechiaB6
RU2136283C1Russian FederationC1
US5952005AUnited States of AmericaA
SK280362B6SlovakiaB6
EP0642335B1European Patent Office (EPO)B1
AT189771TThis recordAustriaT
ATE189771T1AustriaT1
DE69423028D1GermanyD1
ES2144516T3SpainT3
DK0642335T3DenmarkT3
PT642335EPortugalE
GR3033325T3GreeceT3
DE69423028T2GermanyT2
NO310015B1NorwayB1
AU680891CAustraliaC
KR100316206B1Republic of KoreaB1
CN1104891CChinaC
FI113743BFinlandB
EP0642335B2European Patent Office (EPO)B2
DK0642335T4DenmarkT4
ES2144516T5SpainT5
CA2135639CCanadaC
DE69423028T3GermanyT3
JP4107678B2JapanB2
HU227344B1HungaryB1